Related references
Note: Only part of the references are listed.Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naive Prostate Cancer: 3-Year Open Label Followup Results
Bertrand Tombal et al.
JOURNAL OF UROLOGY (2018)
Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth
Jacob Kach et al.
MOLECULAR CANCER THERAPEUTICS (2017)
ELF5-Mediated AR Activation Regulates Prostate Cancer Progression
Kai Li et al.
SCIENTIFIC REPORTS (2017)
Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic
Yusuke Imamura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2016)
New dimension of glucocorticoids in cancer treatment
Kai-Ti Lin et al.
STEROIDS (2016)
Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?
Ben G. L. Vanneste et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
Daniel E. Spratt et al.
CANCER RESEARCH (2015)
Targeting the glucocorticoid receptor in breast and prostate cancers
Jacob Kach et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors
Ning Xie et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Enzalutamide (Xtandi) for Patients With Metastatic, Resistant Prostate Cancer
Lunawati L. Bennett et al.
ANNALS OF PHARMACOTHERAPY (2014)
Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer
Masis Isikbay et al.
HORMONES & CANCER (2014)
New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells
Kuo-Pao Lai et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells
Biswajyoti Sahu et al.
CANCER RESEARCH (2013)
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
Vivek K. Arora et al.
CELL (2013)
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Robert H. Oakley et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate Cancer
Helmut Bonkhoff
PROSTATE CANCER (2012)
High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin
Yasuhiro Kidera et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2011)
Castration-Resistant Prostate Cancer Current and Emerging Treatment Strategies
Giuseppe Di Lorenzo et al.
DRUGS (2010)
Molecular processes leading to aberrant androgen receptor signaling and castration resistance in prostate cancer
Rong Hu et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2010)
The glucocorticoid responses are shaped by molecular chaperones
Wona Grad et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
The human glucocorticoid receptor: One gene, multiple proteins and diverse responses
JG Zhou et al.
STEROIDS (2005)
Structural basis of androgen receptor binding to selective androgen response elements
PL Shaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines
AY Liu et al.
PROSTATE (2004)
A systematic overview of radiation therapy effects in prostate cancer
S Nilsson et al.
ACTA ONCOLOGICA (2004)
Cyclic nucleotide phosphodiesterases
DM Essayan
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status
H Bonkhoff
ANNALS OF ONCOLOGY (2001)
Share Paper
